BRIEF-U.S.-listed shares of Acasti Pharma up 10.7 percent premarket

Thu Jan 9, 2014 8:05am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

NEW YORK Jan 9 (Reuters) - Acasti Pharma Inc : * U.S.-listed shares of Acasti Pharma up 10.7 percent to $1.55 in premarket after the FDA clears its investigational new drug submission to conduct a pharmacokinetic trial